PatientMatch — Privacy-first clinical trial discovery

392 trials

Lung CancerRecruiting now

Enrolling now24

Nationwide

A Clinical Trial of MK-1084 and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

Merck Sharp & Dohme LLC

Ph 3·~7yr·7 sites in AL, CT, FL +4

Enrolling now

9q~2min

Check if I qualify View study

Nationwide

ARTEMIDE-Lung04 Trial

AstraZeneca

Ph 3·~6yr·31 sites in DE, FL, GA +14

Enrolling now

14q~4min

Check if I qualify View study

Nationwide

A Global Phase III Trial of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

AstraZeneca

Ph 3·~5yr·73 sites in AR, AZ, CA +26

Enrolling now

9q~2min

Check if I qualify View study

Nationwide

A Phase 1 Clinical Trial of NXP900 in Subjects With Advanced Cancers

Nuvectis Pharma, Inc.

Ph 1·~4yr·10 sites in AZ, CO, FL +5

Enrolling now

14q~4min

Check if I qualify View study

Nationwide

A Phase 1 Dose Escalation Trial of ZG006 in Patients With Small Cell Lung Cancer

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Ph 1·~2yr·6 sites in CA, FL, KY +2

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

EpiBiologics

Ph 1·5 sites in CA, NJ, TN +1

Enrolling now

7q~2min

Check if I qualify View study

Nationwide

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Iambic Therapeutics, Inc

Ph 1·~4yr·29 sites in CA, CO, FL +15

Enrolling now

11q~3min

Check if I qualify View study

Nationwide

A Phase 1/2a Study of VS-7375

Verastem, Inc.

Ph 1/2·~3yr·12 sites in CA, MA, MD +9

Enrolling now

11q~3min

Check if I qualify View study

Nationwide

A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC

Eikon Therapeutics

Ph 2·~4yr·39 sites in AL, AZ, CA +16

Enrolling now

10q~3min

Check if I qualify View study

Nationwide

A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

Amgen

Ph 3·~4yr·35 sites in AR, AZ, CA +18

Enrolling now

10q~3min

Check if I qualify View study

Nationwide

A Study Evaluating FMC-376

Frontier Medicines Corporation

Ph 1/2·~4yr·15 sites in CA, FL, IN +7

Enrolling now

9q~2min

Check if I qualify View study

Nationwide

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Mirati Therapeutics Inc.

Ph 3·~7yr·47 sites in AL, AR, CA +17

Enrolling now

7q~2min

Check if I qualify View study

Nationwide

A Study of Amivantamab and Olomorasib Combination Therapy

Janssen Research & Development, LLC

Ph 1/2·~3yr·6 sites in CA, NY, PA +3

Enrolling now

15q~4min

Check if I qualify View study

Nationwide

A Study of BIO 300 and Thoracic Radiation Therapy

Memorial Sloan Kettering Cancer Center

Ph 2·~3yr·7 sites in NJ, NY

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

A Study of BMS-986504 in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)

Bristol-Myers Squibb

Ph 2·~6yr·12 sites in AK, ID, MA +7

Enrolling now

6q~2min

Check if I qualify View study

Nationwide

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Clasp Therapeutics, Inc.

Ph 1·~3yr·21 sites in AZ, CA, FL +10

Enrolling now

8q~2min

Check if I qualify View study

Nationwide

A Study of EP0031 in Patients With Advanced RET-altered Malignancies

Ellipses Pharma

Ph 1/2·~5yr·18 sites in CA, DC, FL +11

Enrolling now

11q~3min

Check if I qualify View study

Nationwide

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Daiichi Sankyo

Ph 2·~5yr·13 sites in CA, CT, FL +8

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Daiichi Sankyo

Ph 3·29 sites in AR, CA, FL +15

Enrolling now

6q~2min

Check if I qualify View study

Nationwide

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

Merck Sharp & Dohme LLC

Ph 3·~12yr·68 sites in AK, AZ, CA +26

Enrolling now

10q~3min

Check if I qualify View study

Nationwide

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

Johnson & Johnson Enterprise Innovation Inc.

Procedure·Ph 2·~4yr·15 sites in CT, FL, GA +8

Enrolling now

13q~3min

Check if I qualify View study

Nationwide

A Study of KK2269 in Adult Participants With Solid Tumors

Kyowa Kirin Co., Ltd.

Ph 1·~4yr·7 sites in AZ, CA, FL +3

Enrolling now

10q~3min

Check if I qualify View study

Nationwide

Mental Health Care for Cancer Patients

Memorial Sloan Kettering Cancer Center

~3yr·1 site in NY

Enrolling now

8q~2min

Check if I qualify View study

Nationwide

Lung Cancer Treatment Trial

Genentech, Inc.

Procedure·Ph 2·~10yr·38 sites in CA, CO, CT +15

Enrolling now

14q~4min

Check if I qualify View study